MARIPOSA-2 study

OncoDaily

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary

Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

April, 2025

MARIPOSA-2 study

Apr 2, 2025, 07:50 | Opinion

Eric Singhi: How MARIPOSA and MARIPOSA-2 studies differ

Eric Singhi, Assistant Professor in the Department of General Oncology at The University of Texas…

Oct 5, 2024, 02:12 | Insight

Eric K. Singhi: FDA Oncology approves amivantamab and chemo for EGFR and NSCLC

Eric K. Singhi shared a post on X: “FDA Oncology approves amivantamab and chemo for…

All: 2 Posts: 1 - 100

'

Eric Abidal and Liver Cancer: How He Returned to Football After Overcoming Illness

'

April is Head and Neck Cancer Awareness Month

'

Is Cancer Hereditary? Myths and Facts about Cancer Genetics

'

Neuroendocrine Lung Tumors: Types, Symptoms, Diagnosis, Treatment and 2025 updates

'

Cancer Center Near Me: Dana-Farber Cancer Institute

Special Coverage

Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
ESMO 2024 Congress
September 13-17, 2024
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023